Immersive Virtual Reality for Older Adults in Long-Term Care Settings

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60+
SponsorLaval University

About this trial

The goal of this clinical trial is to learn if an immersive virtual reality mindfulness meditation program is feasible and acceptable for older adults living in long-term care settings in Quebec who have mild to moderate neurocognitive disorder. It will also learn about the safety and potential effects of the program on well-being.

The main questions it aims to answer are:

* Is the virtual reality mindfulness meditation program feasible and acceptable for residents and staff in long-term care settings? * Does the adapted version of the program show potential benefits for well-being, including depression, anxiety, quality of life, mindfulness, pain, and loneliness? * What practical challenges, user experiences, and side effects, such as cybersickness, occur during the program?

Researchers will compare the original Toujours Dimanche virtual reality mindfulness meditation program, an adapted version of Toujours Dimanche designed for older adults with mild to moderate neurocognitive disorder, and standard care alone to see if the adapted program is feasible, acceptable, and potentially helpful.

Participants will:

* Take part in up to 8 virtual reality mindfulness meditation sessions over 4 weeks, if assigned to a virtual reality group * Complete questionnaires before and after the 4-week study period * Share feedback about their experience, when possible * Be observed by staff or research team members to document feasibility, acceptability, user experience, and safety

Eligibility criteria

Qualifiers

Resident of a participating long-term care facility, seniors' home, or alternative seniors' home in the Chaudière-Appalaches or Capitale-Nationale regions of Quebec

Aged 60 years or older

Able to understand French or English

Able to provide informed consent or assent, or have consent provided by a legally authorized representative or person authorized to consent

Disqualifiers

Recurrent migraines

Epilepsy

Traumatic brain injury during the past year

Glaucoma or recovery from eye surgery

Trial design

Treatments tested in this trial

  • Guided Mindfulness Meditation
  • Adapted Virtual Reality Mindfulness Meditation Program
  • Usual Care

Treatment groups

36 Participants
are divided into 3 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Laval University

Lead sponsor

McGill University

Collaborator

Université de Sherbrooke

Collaborator